Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 Oct;12(2):263–272.

The in vitro activity of peritoneal exudate cells from New Zealand Black mice (NZB/B1) in the presence of I125-BSA (bovine serum albumin)

H I Janet Thomas, D M Weir
PMCID: PMC1553570  PMID: 4675200

Abstract

Peritoneal exudate cells from old NZB/B1 mice were found to be more active in taking up I125-labelled bovine serum albumin than similar cells from age matched BALB/c, C57B1 and CBA mice. The cells from both young and old NZB/B1 mice were markedly less able to degrade the ingested antigen than cells from the other strains. These observations are discussed in relation to the development of autoimmune phenomena in the NZB/B1 strain.

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASKONAS B. A., RHODES J. M. IMMUNOGENICITY OF ANTIGEN-CONTAINING RIBONUCLEIC ACID PREPARATIONS FROM MACROPHAGES. Nature. 1965 Jan 30;205:470–474. doi: 10.1038/205470a0. [DOI] [PubMed] [Google Scholar]
  2. Adler W. H., Takiguchi T., Marsh B., Smith R. T. Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens. J Exp Med. 1970 Jun 1;131(6):1049–1078. doi: 10.1084/jem.131.6.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BIELSCHOWSKY M., BIELSCHOWSKY F. OBSERVATIONS ON NZB/B1 MICE; DIFFERENTIAL FERTILITY IN RECIPROCAL CROSSES AND THE TRANSMISSION OF THE AUTO-IMMUNE HAEMOLYTIC ANAEMIA TO NZB/B1 X NZC/B1 HYBRIDS. Aust J Exp Biol Med Sci. 1964 Aug;42:561–568. [PubMed] [Google Scholar]
  4. Barnes R. D., Tuffrey M. A. A transplacental factor in the disease of the autoimmune NZB-BL mouse. Lancet. 1969 Jun 21;1(7608):1240–1242. doi: 10.1016/s0140-6736(69)92119-9. [DOI] [PubMed] [Google Scholar]
  5. COHN Z. A., BENSON B. THE IN VITRO DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. I. THE INFLUENCE OF INHIBITORS AND THE RESULTS OF AUTORADIOGRAPHY. J Exp Med. 1965 Feb 1;121:279–288. doi: 10.1084/jem.121.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen E. P. Conversion of non-immune cells into antibody-forming cells by RNA. Nature. 1967 Feb 4;213(5075):462–465. doi: 10.1038/213462a0. [DOI] [PubMed] [Google Scholar]
  7. Cohn Z. A. The regulation of pinocytosis in mouse macrophages. I. Metabolic requirements as defined by the use of inhibitors. J Exp Med. 1966 Oct 1;124(4):557–571. doi: 10.1084/jem.124.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diener E. The immune response in NZB and NZB x C3H F1-hybrid mice as measured by the haemolysin plaque technique. Int Arch Allergy Appl Immunol. 1966;30(2):120–131. doi: 10.1159/000229801. [DOI] [PubMed] [Google Scholar]
  9. East J., Branca M. Autoimmune reactions and malignant changes in germ-free New Zealand Black mice. Clin Exp Immunol. 1969 Jun;4(6):621–635. [PMC free article] [PubMed] [Google Scholar]
  10. East J., Prosser P. R., Holborow E. J., Jaquet H. Autoimmune reactions and virus-like particles in germ-free NZB mice. Lancet. 1967 Apr 8;1(7493):755–757. doi: 10.1016/s0140-6736(67)91368-2. [DOI] [PubMed] [Google Scholar]
  11. Ehrenreich B. A., Cohn Z. A. The uptake and digestion of iodinated human serum albumin by macrophages in vitro. J Exp Med. 1967 Nov 1;126(5):941–958. doi: 10.1084/jem.126.5.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Evans M. M., Williamson W. G., Irvine W. J. The appearance of immunological competence at an early age in New Zealand black mice. Clin Exp Immunol. 1968 Jun;3(5):375–383. [PMC free article] [PubMed] [Google Scholar]
  13. FISHMAN M., ADLER F. L. Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen. J Exp Med. 1963 Apr 1;117:595–602. doi: 10.1084/jem.117.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. FISHMAN M. Antibody formation in vitro. J Exp Med. 1961 Dec 1;114:837–856. doi: 10.1084/jem.114.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. FISHMAN M., HAMMERSTROM R. A., BOND V. P. In vitro transfer of macrophage RNA to lymph node cells. Nature. 1963 May 11;198:549–551. doi: 10.1038/198549a0. [DOI] [PubMed] [Google Scholar]
  16. HOLMES M. C., BURNET F. M. EXPERIMENTAL STUDIES OF THYMIC FUNCTION IN NZB MICE AND THE F1 HYBRIDS WITH C3H. Aust J Exp Biol Med Sci. 1964 Oct;42:589–600. doi: 10.1038/icb.1964.55. [DOI] [PubMed] [Google Scholar]
  17. HOLMES M. C., GORIE J., BURNET F. M. Transmission by splenic cells of an autoimmune disease occurring spontaneously in mice. Lancet. 1961 Sep 16;2(7203):638–639. doi: 10.1016/s0140-6736(61)90313-0. [DOI] [PubMed] [Google Scholar]
  18. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  19. Holmes M. C., Burnet F. M. The characteristics of F1 and backcross hybrids between "high leukaemia" (AKR) and "autoimmune" (NZB) mouse strains. Aust J Exp Biol Med Sci. 1966 Jun;44(3):235–249. doi: 10.1038/icb.1966.24. [DOI] [PubMed] [Google Scholar]
  20. Lambert P. H., Dixon F. J. Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections. Clin Exp Immunol. 1970 Jun;6(6):829–839. [PMC free article] [PubMed] [Google Scholar]
  21. Leventhal B. G., Talal N. Response of NZB and NZB-NZW spleen cells to mitogenic agents. J Immunol. 1970 Apr;104(4):918–923. [PubMed] [Google Scholar]
  22. Mellors R. C., Huang C. Y. Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med. 1966 Dec 1;124(6):1031–1038. doi: 10.1084/jem.124.6.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mellors R. C., Huang C. Y. Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med. 1967 Jul 1;126(1):53–62. doi: 10.1084/jem.126.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mellors R. C. Murine leukemialike virus and the immunopathologic disorders of New Zealand black mice. J Infect Dis. 1969 Oct;120(4):480–487. doi: 10.1093/infdis/120.4.480. [DOI] [PubMed] [Google Scholar]
  25. Playfair J. H. Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology. 1968 Jul;15(1):35–50. [PMC free article] [PubMed] [Google Scholar]
  26. Playfair J. H. Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology. 1971 Dec;21(6):1037–1043. [PMC free article] [PubMed] [Google Scholar]
  27. Siegel B. V., Brooks R. E., Morton J. I. Ultrastructural aspects of antibody plaque-forming cells from clinically normal and overtly autoimmune NZB mice. Blood. 1970 Mar;35(3):386–393. [PubMed] [Google Scholar]
  28. Staples P. J., Talal N. Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med. 1969 Jan 1;129(1):123–139. doi: 10.1084/jem.129.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stutman O., Yunis E. J., Good R. A. Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med. 1968 Apr;127(4):1204–1207. doi: 10.3181/00379727-127-32910. [DOI] [PubMed] [Google Scholar]
  30. Weir D. M., McBride W., Naysmith J. D. Immune response to a soluble protein antigen in NZB mice. Nature. 1968 Sep 21;219(5160):1276–1277. doi: 10.1038/2191276a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES